Nektar Therapeutics | NKTR - Gross Profit On Sales

Stock Price
67.03
Daily Change
11.03 19.70%
Monthly
72.89%
Yearly
511.31%
Q1 Forecast
1.21

Nektar Therapeutics reported $13.75M in Gross Profit on Sales for its fiscal quarter ending in June of 2024.





Gross Profit On Sales Change Date
Agios Pharmaceuticals USD 11.2M 448K Sep/2025
ALKERMES USD 265.83M 8.06M Sep/2025
Amgen USD 6.48B 307M Sep/2025
Baxter International USD 950M 194M Sep/2025
BioCryst Pharmaceuticals USD -88.88M 202.74M Dec/2024
Biogen USD 1.65B 34.6M Dec/2025
Bristol-Myers Squibb USD 8.79B 110M Sep/2025
Cara Therapeutics USD 2.57M 1.11M Mar/2025
Cipla INR 41.64B 6.31B Dec/2025
Dr.Reddys Laboratories INR 51.37B 629M Dec/2025
Eisai JPY 168.85B 17.02B Dec/2025
Eli Lilly USD 14.59B 1.48B Sep/2025
Esperion Therapeutics USD -29.52M 32.4M Sep/2024
Exelixis USD 572.18M 7M Dec/2025
Gilead Sciences USD 6.31B 106M Dec/2025
GlaxoSmithKline GBP 6.18B 106M Dec/2025
Grifols EUR 766.49M 39.74M Dec/2024
Halozyme Therapeutics USD 281.77M 2.41M Sep/2025
Incyte USD 1.39B 118.68M Dec/2025
Ionis Pharmaceuticals USD 155M 293M Sep/2025
Ironwood Pharmaceuticals USD 85.24M 44.1M Jun/2025
Karyopharm Therapeutics USD -30.78M 1.29M Dec/2024
MacroGenics USD 61.25M 88.71M Sep/2025
Merck USD 13.42B 431M Sep/2025
Nektar Therapeutics USD 13.75M 650K Jun/2024
Neurocrine Biosciences USD 780.9M 104.7M Sep/2025
Novartis USD 10.82B 695M Sep/2025
Pfizer USD 3.54B 7.61B Sep/2025
Roche Holding CHF 22.09B 10.04B Dec/2025
Sarepta Therapeutics USD 247.9M 209.96M Sep/2025
Takeda JPY 790.55B 262.97B Dec/2025
Teva Pharmaceutical Industries USD 2.66B 351M Dec/2025
Xencor USD 21M 22.61M Sep/2025